ISSN: 2475-3173

Cervical Cancer: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial Note   
  • Cervical Cancer 2022, Vol 7(1): 115
  • DOI: 10.4172/2475-3173.1000115

An Overview of Novel Agents for Cervical Cancer Therapy by Inducing Apoptosis: Emerging Drugs On-going Clinical Trials and Preclinical reviews

Tanja Sarenac*
Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
*Corresponding Author : Tanja Sarenac, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia, Email: tanjica.tanjci@gmail.com

Received Date: Feb 12, 2022 / Accepted Date: Feb 24, 2022 / Published Date: Feb 25, 2022

Citation: Sarenac T (2022) An Overview of Novel Agents for Cervical Cancer Therapy by Inducing Apoptosis: Emerging Drugs On-going Clinical Trials and Preclinical reviews. Cervical Cancer, 7: 115. Doi: 10.4172/2475-3173.1000115

Copyright: © 2022 Sarenac T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top